Global Neurovascular Embolization Devices Market 2023: Minimally Invasive Surgery to Treat Brain Aneurysms by Embolization Coils Aids Steady Revenue Generation

The neurovascular embolization device market is growing rapidly with huge potential for growth as the use of these devices increases across both developed and emerging economies. Neurovascular embolization devices are medical tools used to prevent ruptures or treat aneurysms in arteries located in the head and neck area by using small particles to block blood flow. These devices have become increasingly popular due to their minimally invasive nature compared to traditional open surgery approaches.

This impressive growth trend can be attributed to factors such as technological advancements in this field with modern day embolic coils being made of more resilient and flexible materials which helps create more precise implants; something which drives down overall complications associated with this procedure significantly when compared to traditional treatments. In addition, there continues be emphasis on creating smarter software designs allowing greater control insertion procedure whilst providing user friendly interfaces enabling surgeons diagnose & proceed treatment quickly efficiently move forward - all part larger picture aiming create better patient outcomes better healthcare experiences long term.

Request For Free Sample Report of "Neurovascular Embolization Devices Market"@ https://www.persistencemarketresearch.com/samples/25969

It is claimed by the Brain Aneurysm Foundation that around 6 million people in the U.S. suffer from brain aneurysms, which is expected to fuel the adoption minimally invasive neurovascular procedure. More than 500,000 people worldwide die due to stroke and other disorders associated with cerebral aneurysms, which is also increasing the demand for neurovascular embolization devices. Intracranial aneurysm is prevalent in individuals younger than 60 years, as half out of the total mortality rate due to brain aneurysms comprises share of young individuals below age 50.

It is been found by the Brain Aneurysm Foundation that about 15% of individuals possessing aneurysms in the neurovascular tract are very likely to have more than one aneurysm. This factor further increases the demand for neurovascular embolization devices from the individuals suffering from cerebral aneurysms. Neurovascular aneurysms if not treated can result in severe consequences of neurological defects and permanent impairment of cognitive functions in the absence of neurovascular embolization devices. The observations of these outcomes from brain aneurysms is also projected to fuel the demand for neurovascular embolization devices over the forecast period.

Neurovascular embolization devices are majorly adopted by hospitals owing to the requirement of high-end technological devices for the purpose of visualization, navigation, precision and complex nature of the surgery. The outpatient centers segment is projected to grow at a CAGR of 4.8% over the forecast period due to increasing demand for minimally invasive surgeries.

With significant presence of key players and high healthcare expenditure, North America is projected to be the dominant regional market for neurovascular embolization devices over the forecast period. Asia Pacific neurovascular embolization devices market is projected to grow at a CAGR of 5.2% due to growing awareness regarding brain aneurysms and other neurovascular diseases as well as significant presence of key manufacturers.

Buy Full Report Now@ https://www.persistencemarketresearch.com/checkout/25969

Companies

Medtronic plc
Stryker Corporation
Terumo Corporation
Johnson & Johnson Services, Inc.
Penumbra Inc.
Balt Extrusion S.A
Braun Melsungen AG.
Integra LifeSciences Corporation
Resonetics Llc
Acandis GmbH

The company has segmented the global neurovascular embolization devices market based on product type, end user and region. In terms of revenue, the embolization devices product type segment of the neurovascular embolization devices market is expected to hold significant share and grow at a high CAGR of 4.9% in the global neurovascular embolization devices market over the forecast period. Flow diversion stents segment in the neurovascular embolization devices market is also expected to grow at a significant CAGR owing to the low associated risks and their growing adoption by the end users. Aneurysm clips segment in the neurovascular embolization devices market is estimated to contribute 2.4% market share in the terms of revenue. These devices have witness significant decrease in demand due to invasive nature of the treatment.

Additionally, the hospital end-use segment in the neurovascular embolization devices market is predicted to exhibit growth by 4.2% CAGR during the forecast period. However, outpatient Centres hold key growth opportunity due to emergence of minimally invasive treatment modalities such as embolization coils, liquid embolic systems. North America neurovascular embolization devices market is estimated to create an incremental opportunity of US$ 229.7 Mn between 2018 and 2028.

The report tracks some of the key companies operating in the neurovascular embolization devices market, including Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A., Terumo Corporation, and Johnson and Johnson Services, Inc.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/25969

Key Questions Answered in This Report.

What are the Roadblocks for Neurovascular Embolization Devices Market Suppliers?
What are the Key Opportunities for Neurovascular Embolization Devices Market Manufacturers?
How is Focus on Safety Influencing Neurovascular Embolization Devices Market Demand?
What is the Regulatory Impact on Global Sales of Neurovascular Embolization Devices Market?
Which Region Offers the Largest Opportunity for Sales of Neurovascular Embolization Devices Market?
Where Does the U.S. Stand in the Market for Neurovascular Embolization Devices Market?
What Is the Outlook for Neurovascular Embolization Devices Market Manufacturers in China?
Why is Germany a Lucrative Market for Neurovascular Embolization Devices Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Neurovascular Embolization Devices Market?
Why is There High Demand for Tires in Neurovascular Embolization Devices Market?
Why are Sales of Neurovascular Embolization Devices Market Surging?

Related Market Research Reports:

Molecular Diagnostics in Infectious Disease Testing market - https://www.globenewswire.com/en/news-release/2022/10/25/2541042/0/en/Molecular-Diagnostics-in-Infectious-Disease-Testing-Market-Revenue-to-Hit-US-85-Bn-by-2032-Persistence-Market-Research.html

Hypercholesterolemia Treatment market - https://www.globenewswire.com/en/news-release/2022/10/21/2539307/0/en/Hypercholesterolemia-Treatment-Market-Size-Share-and-Trends-Industry-Growing-at-a-CAGR-of-2-3-by-end-of-2022-Persistence-Market-Research.html

Acquired Orphan Blood Disease market - https://www.globenewswire.com/en/news-release/2022/10/20/2538543/0/en/Acquired-Orphan-Blood-Disease-Market-reach-a-growth-of-US-21-5-Bn-by-2032-Persistence-Market-Research.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.